# EDGAR Filing Document

**Accession Number:** 0000945908
**File Stem:** 0001410368-26-063876
**Filing Date:** 2026-6
**Character Count:** 189998
**Document Hash:** 21a993afcdbc85f441e147060d18dfc5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-26-063876.hdr.sgml**: 20260623

**ACCESSION NUMBER**: 0001410368-26-063876

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260430

**FILED AS OF DATE**: 20260623

**DATE AS OF CHANGE**: 20260623

**PERIOD START**: 20260731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FIDELITY COVINGTON TRUST
- **CENTRAL INDEX KEY:** 0000945908

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-07319
- **FILM NUMBER:** 261109464

**BUSINESS ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 617-563-7000

**MAIL ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

## Series and Classes Contracts Data

### Fidelity MSCI Health Care Index ETF (Series ID: S000042575)

| Class ID   | Class Name                          | Ticker Symbol   |
|:---|:---|:---|
| C000131667 | Fidelity MSCI Health Care Index ETF | FHLC            |

## Nport-Ex

### Quarterly Holdings Report

### for

### Fidelity® MSCI Health Care Index ETF

### April 30, 2026
T05-NPRT3-0626

1.9584810.112 ------

### Schedule of Investments April 30, 2026 (Unaudited)
Showing Percentage of Net Assets

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – 99.8%** | &nbsp;&nbsp;**Common Stocks – 99.8%** | &nbsp;&nbsp;**Common Stocks – 99.8%** |
|  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **BIOTECHNOLOGY – 22.8%** | **BIOTECHNOLOGY – 22.8%** | **BIOTECHNOLOGY – 22.8%** |
| **Biotechnology – 22.8%** | **Biotechnology – 22.8%** | **Biotechnology – 22.8%** |
| AbbVie, Inc. | 815990 | &nbsp;&nbsp;&nbsp;$172435007 |
| ACADIA Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;54956 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1233762 |
| ADMA Biologics, Inc. (a) | 109138 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1118665 |
| Agios Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;25231 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;706468 |
| Akero Therapeutics, Inc. (a) | &nbsp;&nbsp;22341 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 |
| Akouos, Inc. (a) | &nbsp;&nbsp;11863 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2254 |
| Alkermes PLC (a) | &nbsp;&nbsp;72512 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2444380 |
| Alnylam Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;60996 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18877652 |
| Amgen, Inc. | 248613 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;86082251 |
| AnaptysBio, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;6418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;421855 |
| Annexon, Inc. (a) | &nbsp;&nbsp;54687 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;321013 |
| Apellis Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;35150 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1439393 |
| Apogee Therapeutics, Inc. (a) | &nbsp;&nbsp;17612 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1459859 |
| Arbutus Biopharma Corp. (a) | &nbsp;&nbsp;64437 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;270635 |
| Arcellx, Inc. (a) | &nbsp;&nbsp;12690 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;888 |
| Arcus Biosciences, Inc. (a) | &nbsp;&nbsp;40376 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1029588 |
| Arcutis Biotherapeutics, Inc. (a) | &nbsp;&nbsp;50560 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1174003 |
| Ardelyx, Inc. (a) | 111086 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;703174 |
| ArriVent Biopharma, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9868 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;306796 |
| Arrowhead Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;56550 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4155294 |
| ARS Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;24917 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;205814 |
| Aurinia Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;52025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;800405 |
| Beam Therapeutics, Inc. (a) | &nbsp;&nbsp;42166 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1278895 |
| Bicara Therapeutics, Inc. (a) | &nbsp;&nbsp;12760 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;275361 |
| BioCryst Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;96151 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;880743 |
| Biogen, Inc. (a) | &nbsp;&nbsp;67766 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12826749 |
| Biohaven Ltd. (a) | &nbsp;&nbsp;59940 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;574825 |
| BioMarin Pharmaceutical, Inc. (a) | &nbsp;&nbsp;84082 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4532861 |
| Bridgebio Pharma, Inc. (a) | &nbsp;&nbsp;66688 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4742184 |
| Capricor Therapeutics, Inc. (a) | &nbsp;&nbsp;22465 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;754375 |
| CareDx, Inc. (a) | &nbsp;&nbsp;24115 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;501833 |
| Catalyst Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;54185 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1524224 |
| Celcuity, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9556 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1159621 |
| Celldex Therapeutics, Inc. (a) | &nbsp;&nbsp;30973 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1018392 |
| CG oncology, Inc. (a) | &nbsp;&nbsp;19705 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1315112 |
| Chinook Therapeutics, Inc. (a) | &nbsp;&nbsp;24218 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 |
| Cogent Biosciences, Inc. (a) | &nbsp;&nbsp;38351 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1372582 |
| Compass Therapeutics, Inc. (a) | &nbsp;&nbsp;51153 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90541 |
| CRISPR Therapeutics AG (a) | &nbsp;&nbsp;39903 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2088523 |
| Cullinan Therapeutics, Inc. (a) | &nbsp;&nbsp;14784 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;192931 |
| Cytokinetics, Inc. (a) | &nbsp;&nbsp;53720 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3436468 |
| CytomX Therapeutics, Inc. (a) | &nbsp;&nbsp;74256 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;313360 |
| Denali Therapeutics, Inc. (a) | &nbsp;&nbsp;64790 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1212869 |
| Dianthus Therapeutics, Inc. (a) | &nbsp;&nbsp;16047 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1408927 |
| Disc Medicine, Inc. (a) | &nbsp;&nbsp;11162 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;736134 |
| Dyne Therapeutics, Inc. (a) | &nbsp;&nbsp;53716 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;942716 |
| Erasca, Inc. (a) | &nbsp;&nbsp;78076 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;831509 |
| Exelixis, Inc. (a) | 117751 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5235209 |
| First Tracks Biotherapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;6418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;149347 |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Geron Corp. (a) | 230599 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$355122 |
| Gilead Sciences, Inc. | 572814 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;74946984 |
| GRAIL, Inc. (a) | &nbsp;&nbsp;16096 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;876910 |
| Halozyme Therapeutics, Inc. (a) | &nbsp;&nbsp;54463 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3467115 |
| Ideaya Biosciences, Inc. (a) | &nbsp;&nbsp;36855 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1072481 |
| ImmunityBio, Inc. (a) | 158131 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1122730 |
| Immunome, Inc. (a) | &nbsp;&nbsp;42979 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;985938 |
| Immunovant, Inc. (a) | &nbsp;&nbsp;36741 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;997334 |
| Incyte Corp. (a) | &nbsp;&nbsp;77137 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7348842 |
| Inhibrx Biosciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;3333 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;430657 |
| Insmed, Inc. (a) | &nbsp;&nbsp;98520 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13431232 |
| Intellia Therapeutics, Inc. (a) | &nbsp;&nbsp;50707 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;683530 |
| Ionis Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;70978 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5306315 |
| Iovance Biotherapeutics, Inc. (a) | 140923 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;473501 |
| Janux Therapeutics, Inc. (a) | &nbsp;&nbsp;17660 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;253774 |
| KalVista Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;13259 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;353485 |
| Kiniksa Pharmaceuticals International PLC (a) | &nbsp;&nbsp;16563 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;890758 |
| Kodiak Sciences, Inc. (a) | &nbsp;&nbsp;13317 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;579023 |
| Krystal Biotech, Inc. (a) | &nbsp;&nbsp;10084 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2644630 |
| Kura Oncology, Inc. (a) | &nbsp;&nbsp;34421 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;303937 |
| Kymera Therapeutics, Inc. (a) | &nbsp;&nbsp;21910 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1776244 |
| Madrigal Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;6819 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3528082 |
| MannKind Corp. (a) | 135688 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;383997 |
| MiMedx Group, Inc. (a) | &nbsp;&nbsp;52532 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;176508 |
| Mineralys Therapeutics, Inc. (a) | &nbsp;&nbsp;20978 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;559064 |
| Mirum Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;17493 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1702244 |
| Moderna, Inc. (a) | 162167 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7449952 |
| Monte Rosa Therapeutics, Inc. (a) | &nbsp;&nbsp;14154 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;271049 |
| MoonLake Immunotherapeutics (a) | &nbsp;&nbsp;14568 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;238624 |
| Myriad Genetics, Inc. (a) | &nbsp;&nbsp;41272 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;196042 |
| Natera, Inc. (a) | &nbsp;&nbsp;60725 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12519066 |
| Neurocrine Biosciences, Inc. (a) | &nbsp;&nbsp;45968 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6052607 |
| Newamsterdam Pharma Co. NV (a) | &nbsp;&nbsp;21169 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;604587 |
| Novavax, Inc. (a) | &nbsp;&nbsp;62651 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;496509 |
| Nurix Therapeutics, Inc. (a) | &nbsp;&nbsp;34589 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;577636 |
| Nuvalent, Inc. Class A (a) | &nbsp;&nbsp;18465 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1851670 |
| Olema Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;17308 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;249408 |
| ORIC Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;20039 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;197985 |
| Oruka Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9959 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;681295 |
| Palvella Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;4496 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;576927 |
| Praxis Precision Medicines, Inc. (a) | &nbsp;&nbsp;10867 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3464726 |
| Precigen, Inc. (a) | &nbsp;&nbsp;81104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;337393 |
| Prime Medicine, Inc. (a) | &nbsp;&nbsp;39527 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;140123 |
| Protagonist Therapeutics, Inc. (a) | &nbsp;&nbsp;23132 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2289374 |
| PTC Therapeutics, Inc. (a) | &nbsp;&nbsp;33415 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2173980 |
| Recursion Pharmaceuticals, Inc. Class A (a) | 203251 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;703248 |
| Regeneron Pharmaceuticals, Inc. | &nbsp;&nbsp;47685 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33716156 |
| Relay Therapeutics, Inc. (a) | &nbsp;&nbsp;56820 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;736387 |
| Revolution Medicines, Inc. (a) | &nbsp;&nbsp;74740 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10771529 |
| Rhythm Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;26169 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2129110 |

---

 ***Quarterly Report*** <sub>2</sub>

------

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **BIOTECHNOLOGY – continued** | **BIOTECHNOLOGY – continued** | **BIOTECHNOLOGY – continued** | **BIOTECHNOLOGY – continued** |
| **Biotechnology – continued** | **Biotechnology – continued** | **Biotechnology – continued** | **Biotechnology – continued** |
| Roivant Sciences Ltd. (a) | Roivant Sciences Ltd. (a) | 173133 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$4939485 |
| Sana Biotechnology, Inc. (a) | Sana Biotechnology, Inc. (a) | &nbsp;&nbsp;78026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;256706 |
| Sarepta Therapeutics, Inc. (a) | Sarepta Therapeutics, Inc. (a) | &nbsp;&nbsp;45547 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;951021 |
| Savara, Inc. (a) | Savara, Inc. (a) | &nbsp;&nbsp;31710 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;166160 |
| Scholar Rock Holding Corp. (a) | Scholar Rock Holding Corp. (a) | &nbsp;&nbsp;28968 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1350199 |
| Soleno Therapeutics, Inc. (a) | Soleno Therapeutics, Inc. (a) | &nbsp;&nbsp;21263 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1123112 |
| Spyre Therapeutics, Inc. (a) | Spyre Therapeutics, Inc. (a) | &nbsp;&nbsp;22417 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1668946 |
| Stoke Therapeutics, Inc. (a) | Stoke Therapeutics, Inc. (a) | &nbsp;&nbsp;18412 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;602441 |
| Syndax Pharmaceuticals, Inc. (a) | Syndax Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;37483 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;803261 |
| Tango Therapeutics, Inc. (a) | Tango Therapeutics, Inc. (a) | &nbsp;&nbsp;20381 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;440637 |
| Taysha Gene Therapies, Inc. (a) | Taysha Gene Therapies, Inc. (a) | &nbsp;&nbsp;62485 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;399279 |
| TG Therapeutics, Inc. (a) | TG Therapeutics, Inc. (a) | &nbsp;&nbsp;69640 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2352439 |
| Travere Therapeutics, Inc. (a) | Travere Therapeutics, Inc. (a) | &nbsp;&nbsp;39584 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1667278 |
| Twist Bioscience Corp. (a) | Twist Bioscience Corp. (a) | &nbsp;&nbsp;28085 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1641568 |
| Tyra Biosciences, Inc. (a) | Tyra Biosciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;6122 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;212740 |
| Ultragenyx Pharmaceutical, Inc. (a) | Ultragenyx Pharmaceutical, Inc. (a) | &nbsp;&nbsp;39736 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;981082 |
| uniQure NV (a) | uniQure NV (a) | &nbsp;&nbsp;18008 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;359260 |
| United Therapeutics Corp. (a) | United Therapeutics Corp. (a) | &nbsp;&nbsp;18901 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10799086 |
| Upstream Bio, Inc. (a) | Upstream Bio, Inc. (a) | &nbsp;&nbsp;11160 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;102449 |
| UroGen Pharma Ltd. (a) | UroGen Pharma Ltd. (a) | &nbsp;&nbsp;18033 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;429726 |
| Vaxcyte, Inc. (a) | Vaxcyte, Inc. (a) | &nbsp;&nbsp;54647 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3127994 |
| Vera Therapeutics, Inc. (a) | Vera Therapeutics, Inc. (a) | &nbsp;&nbsp;17563 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;625418 |
| Veracyte, Inc. (a) | Veracyte, Inc. (a) | &nbsp;&nbsp;36188 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1191309 |
| Vericel Corp. (a) | Vericel Corp. (a) | &nbsp;&nbsp;23722 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;823865 |
| Vertex Pharmaceuticals, Inc. (a) | Vertex Pharmaceuticals, Inc. (a) | 117140 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50063293 |
| Viking Therapeutics, Inc. (a) | Viking Therapeutics, Inc. (a) | &nbsp;&nbsp;49795 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1552608 |
| Vir Biotechnology, Inc. (a) | Vir Biotechnology, Inc. (a) | &nbsp;&nbsp;54198 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;553633 |
| Viridian Therapeutics, Inc. (a) | Viridian Therapeutics, Inc. (a) | &nbsp;&nbsp;30128 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;406125 |
| Xencor, Inc. (a) | Xencor, Inc. (a) | &nbsp;&nbsp;22923 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;273471 |
| Xenon Pharmaceuticals, Inc. (a) | Xenon Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;36576 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2049719 |
| Zenas Biopharma, Inc. (a) | Zenas Biopharma, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7339 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;141789 |
| Zymeworks, Inc. (a) | Zymeworks, Inc. (a) | &nbsp;&nbsp;17797 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;490129 |
| TOTAL BIOTECHNOLOGY | &nbsp;&nbsp;&nbsp;&nbsp;650207495 |  |  |
| **HEALTH CARE EQUIPMENT & SUPPLIES – 16.8%** | **HEALTH CARE EQUIPMENT & SUPPLIES – 16.8%** | **HEALTH CARE EQUIPMENT & SUPPLIES – 16.8%** | **HEALTH CARE EQUIPMENT & SUPPLIES – 16.8%** |
| **Health Care Equipment – 15.8%** | **Health Care Equipment – 15.8%** | **Health Care Equipment – 15.8%** | **Health Care Equipment – 15.8%** |
| Abbott Laboratories | Abbott Laboratories | 802826 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;72888573 |
| Alphatec Holdings, Inc. (a) | Alphatec Holdings, Inc. (a) | &nbsp;&nbsp;54133 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;528338 |
| Artivion, Inc. (a) | Artivion, Inc. (a) | &nbsp;&nbsp;18392 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;658985 |
| AtriCure, Inc. (a) | AtriCure, Inc. (a) | &nbsp;&nbsp;23082 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;648835 |
| Axogen, Inc. (a) | Axogen, Inc. (a) | &nbsp;&nbsp;21500 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;928800 |
| Baxter International, Inc. | Baxter International, Inc. | 237837 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4181174 |
| Becton Dickinson & Co. | Becton Dickinson & Co. | 131589 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19612025 |
| Boston Scientific Corp. (a) | Boston Scientific Corp. (a) | 684434 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;39430243 |
| Butterfly Network, Inc. (a) | Butterfly Network, Inc. (a) | &nbsp;&nbsp;93022 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;445575 |
| CONMED Corp. | CONMED Corp. | &nbsp;&nbsp;14369 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;526768 |
| Dexcom, Inc. (a) | Dexcom, Inc. (a) | 180283 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10735853 |
| Edwards Lifesciences Corp. (a) | Edwards Lifesciences Corp. (a) | 267921 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22371403 |
| Enovis Corp. (a) | Enovis Corp. (a) | &nbsp;&nbsp;26221 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;614620 |
| Envista Holdings Corp. (a) | Envista Holdings Corp. (a) | &nbsp;&nbsp;76092 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1973826 |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| GE HealthCare Technologies, Inc. | GE HealthCare Technologies, Inc. | 210460 | &nbsp;&nbsp;&nbsp;&nbsp;$12804386 |
| Glaukos Corp. (a) | Glaukos Corp. (a) | &nbsp;&nbsp;26450 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3800072 |
| Globus Medical, Inc. Class A (a) | Globus Medical, Inc. Class A (a) | &nbsp;&nbsp;51771 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4668709 |
| Hologic, Inc. (a) | Hologic, Inc. (a) | 100790 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1008 |
| IDEXX Laboratories, Inc. (a) | IDEXX Laboratories, Inc. (a) | &nbsp;&nbsp;36867 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20675014 |
| Inspire Medical Systems, Inc. (a) | Inspire Medical Systems, Inc. (a) | &nbsp;&nbsp;12863 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;722129 |
| Insulet Corp. (a) | Insulet Corp. (a) | &nbsp;&nbsp;32471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5589558 |
| Integer Holdings Corp. (a) | Integer Holdings Corp. (a) | &nbsp;&nbsp;16356 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1447670 |
| Integra LifeSciences Holdings Corp. (a) | Integra LifeSciences Holdings Corp. (a) | &nbsp;&nbsp;29902 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;315167 |
| Intuitive Surgical, Inc. (a) | Intuitive Surgical, Inc. (a) | 163669 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;74896571 |
| iRadimed Corp. | iRadimed Corp. | &nbsp;&nbsp;&nbsp;&nbsp;3851 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;321327 |
| IRhythm Holdings, Inc. (a) | IRhythm Holdings, Inc. (a) | &nbsp;&nbsp;14825 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1914797 |
| Kestra Medical Technologies Ltd. (a) | Kestra Medical Technologies Ltd. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9448 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;195763 |
| LeMaitre Vascular, Inc. | LeMaitre Vascular, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;9837 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1079611 |
| LivaNova PLC (a) | LivaNova PLC (a) | &nbsp;&nbsp;25135 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1510614 |
| Masimo Corp. (a) | Masimo Corp. (a) | &nbsp;&nbsp;21108 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3766300 |
| Medtronic PLC | Medtronic PLC | 591898 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47925981 |
| Novocure Ltd. (a) | Novocure Ltd. (a) | &nbsp;&nbsp;48035 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;730612 |
| Omnicell, Inc. (a) | Omnicell, Inc. (a) | &nbsp;&nbsp;21155 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;876240 |
| Penumbra, Inc. (a) | Penumbra, Inc. (a) | &nbsp;&nbsp;17152 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5599785 |
| Procept Biorobotics Corp. (a) | Procept Biorobotics Corp. (a) | &nbsp;&nbsp;25362 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;609702 |
| Pulse Biosciences, Inc. (a) | Pulse Biosciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9245 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;195717 |
| QuidelOrtho Corp. (a) | QuidelOrtho Corp. (a) | &nbsp;&nbsp;31649 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;389283 |
| ResMed, Inc. | ResMed, Inc. | &nbsp;&nbsp;67421 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14415284 |
| SI-BONE, Inc. (a) | SI-BONE, Inc. (a) | &nbsp;&nbsp;18818 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;233155 |
| STERIS PLC | STERIS PLC | &nbsp;&nbsp;45282 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9820760 |
| Stryker Corp. | Stryker Corp. | 158906 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50076048 |
| Tandem Diabetes Care, Inc. (a) | Tandem Diabetes Care, Inc. (a) | &nbsp;&nbsp;31511 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;615252 |
| Teleflex, Inc. | Teleflex, Inc. | &nbsp;&nbsp;20462 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2535446 |
| TransMedics Group, Inc. (a) | TransMedics Group, Inc. (a) | &nbsp;&nbsp;15145 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1526465 |
| Zimmer Biomet Holdings, Inc. | Zimmer Biomet Holdings, Inc. | &nbsp;&nbsp;91433 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7536822 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;452340266 |
| **Health Care Supplies – 1.0%** | **Health Care Supplies – 1.0%** | **Health Care Supplies – 1.0%** | **Health Care Supplies – 1.0%** |
| Align Technology, Inc. (a) | Align Technology, Inc. (a) | &nbsp;&nbsp;31438 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5533402 |
| Avanos Medical, Inc. (a) | Avanos Medical, Inc. (a) | &nbsp;&nbsp;20939 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;515518 |
| Cooper Cos., Inc. (a) | Cooper Cos., Inc. (a) | &nbsp;&nbsp;90338 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5682260 |
| Dentsply Sirona, Inc. | Dentsply Sirona, Inc. | &nbsp;&nbsp;91834 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1079049 |
| Embecta Corp. | Embecta Corp. | &nbsp;&nbsp;25512 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;233435 |
| Establishment Labs Holdings, Inc. (a) | Establishment Labs Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7971 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;547050 |
| Haemonetics Corp. (a) | Haemonetics Corp. (a) | &nbsp;&nbsp;21461 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1289591 |
| ICU Medical, Inc. (a) | ICU Medical, Inc. (a) | &nbsp;&nbsp;10944 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1304525 |
| Lantheus Holdings, Inc. (a) | Lantheus Holdings, Inc. (a) | &nbsp;&nbsp;30772 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2603927 |
| Merit Medical Systems, Inc. (a) | Merit Medical Systems, Inc. (a) | &nbsp;&nbsp;27451 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1871609 |
| Neogen Corp. (a) | Neogen Corp. (a) | &nbsp;&nbsp;96177 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;904064 |
| Solventum Corp. (a) | Solventum Corp. (a) | &nbsp;&nbsp;72184 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4862314 |
| STAAR Surgical Co. (a) | STAAR Surgical Co. (a) | &nbsp;&nbsp;14691 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;387255 |
| UFP Technologies, Inc. (a) | UFP Technologies, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;3350 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;641961 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27455960 |
| TOTAL HEALTH CARE EQUIPMENT & SUPPLIES | &nbsp;&nbsp;&nbsp;&nbsp;479796226 |  |  |

---

---

| | |
|:---|:---|
| **3** | ***Quarterly Report*** |

---

------

Schedule of Investments (Unaudited)–continued

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** |
|  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **HEALTH CARE PROVIDERS & SERVICES – 18.2%** | **HEALTH CARE PROVIDERS & SERVICES – 18.2%** | **HEALTH CARE PROVIDERS & SERVICES – 18.2%** |
| **Health Care Distributors – 3.4%** | **Health Care Distributors – 3.4%** | **Health Care Distributors – 3.4%** |
| AdaptHealth Corp. (a) | &nbsp;&nbsp;43305 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$567729 |
| Cardinal Health, Inc. | 109696 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21158164 |
| Cencora, Inc. | &nbsp;&nbsp;85087 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26207647 |
| Henry Schein, Inc. (a) | &nbsp;&nbsp;48980 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3653418 |
| McKesson Corp. | &nbsp;&nbsp;56985 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;46454172 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;98041130 |
| **Health Care Facilities – 2.1%** | **Health Care Facilities – 2.1%** | **Health Care Facilities – 2.1%** |
| Acadia Healthcare Co., Inc. (a) | &nbsp;&nbsp;40172 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1040254 |
| Ardent Health, Inc. (a) | &nbsp;&nbsp;13112 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;127973 |
| Brookdale Senior Living, Inc. (a) | 105319 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1512381 |
| Concentra Group Holdings Parent, Inc. | &nbsp;&nbsp;53425 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1200460 |
| Encompass Health Corp. | &nbsp;&nbsp;46407 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4640700 |
| Ensign Group, Inc. | &nbsp;&nbsp;26762 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4996198 |
| HCA Healthcare, Inc. | &nbsp;&nbsp;73749 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32040253 |
| National HealthCare Corp. | &nbsp;&nbsp;&nbsp;&nbsp;6169 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1069026 |
| Nutex Health, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;1700 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;202640 |
| PACS Group, Inc. (a) | &nbsp;&nbsp;21995 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;737932 |
| Select Medical Holdings Corp. | &nbsp;&nbsp;51090 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;838387 |
| Surgery Partners, Inc. (a) | &nbsp;&nbsp;35045 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;491681 |
| Tenet Healthcare Corp. (a) | &nbsp;&nbsp;40613 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7193375 |
| U.S. Physical Therapy, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;6857 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;488356 |
| Universal Health Services, Inc. Class B | &nbsp;&nbsp;25483 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4288024 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60867640 |
| **Health Care Services – 4.6%** | **Health Care Services – 4.6%** | **Health Care Services – 4.6%** |
| Addus HomeCare Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;8452 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;818914 |
| AMN Healthcare Services, Inc. (a) | &nbsp;&nbsp;17137 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;350794 |
| Astrana Health, Inc. (a) | &nbsp;&nbsp;20883 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;712946 |
| Aveanna Healthcare Holdings, Inc. (a) | &nbsp;&nbsp;23951 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;156640 |
| BrightSpring Health Services, Inc. (a) | &nbsp;&nbsp;66653 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3197345 |
| Castle Biosciences, Inc. (a) | &nbsp;&nbsp;13531 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;331374 |
| Chemed Corp. | &nbsp;&nbsp;&nbsp;&nbsp;6563 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2789144 |
| Cigna Group | 123330 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35837231 |
| CorVel Corp. (a) | &nbsp;&nbsp;14092 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;809726 |
| CVS Health Corp. | 586089 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48815353 |
| DaVita, Inc. (a) | &nbsp;&nbsp;17983 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2789883 |
| Fulgent Genetics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;8753 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;132958 |
| GeneDx Holdings Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9194 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;578211 |
| Guardant Health, Inc. (a) | &nbsp;&nbsp;51837 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4513966 |
| Guardian Pharmacy Services, Inc. Class A (a) | &nbsp;&nbsp;11248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;417301 |
| Hims & Hers Health, Inc. (a) | &nbsp;&nbsp;91178 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2477306 |
| Hinge Health, Inc. Class A (a) | &nbsp;&nbsp;&nbsp;&nbsp;8122 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;362241 |
| Labcorp Holdings, Inc. | &nbsp;&nbsp;38323 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9841346 |
| LifeStance Health Group, Inc. (a) | &nbsp;&nbsp;80190 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;607038 |
| NeoGenomics, Inc. (a) | &nbsp;&nbsp;60531 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;560517 |
| OPKO Health, Inc. (a) | 200102 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;225115 |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Option Care Health, Inc. (a) | Option Care Health, Inc. (a) | &nbsp;&nbsp;72815 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1480329 |
| Pediatrix Medical Group, Inc. (a) | Pediatrix Medical Group, Inc. (a) | &nbsp;&nbsp;39438 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;887749 |
| Pennant Group, Inc. (a) | Pennant Group, Inc. (a) | &nbsp;&nbsp;16336 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;511644 |
| Privia Health Group, Inc. (a) | Privia Health Group, Inc. (a) | &nbsp;&nbsp;45158 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1122176 |
| Quest Diagnostics, Inc. | Quest Diagnostics, Inc. | &nbsp;&nbsp;51278 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9958188 |
| RadNet, Inc. (a) | RadNet, Inc. (a) | &nbsp;&nbsp;30424 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1720477 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;132005912 |
| **Managed Health Care – 8.1%** | **Managed Health Care – 8.1%** | **Managed Health Care – 8.1%** | **Managed Health Care – 8.1%** |
| Alignment Healthcare, Inc. (a) | Alignment Healthcare, Inc. (a) | &nbsp;&nbsp;78395 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1767023 |
| Centene Corp. (a) | Centene Corp. (a) | 226652 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12168946 |
| Clover Health Investments Corp. (a) | Clover Health Investments Corp. (a) | 191101 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;525528 |
| Elevance Health, Inc. | Elevance Health, Inc. | 102606 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;38622950 |
| HealthEquity, Inc. (a) | HealthEquity, Inc. (a) | &nbsp;&nbsp;39344 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3227388 |
| Humana, Inc. | Humana, Inc. | &nbsp;&nbsp;55554 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13135188 |
| Molina Healthcare, Inc. (a) | Molina Healthcare, Inc. (a) | &nbsp;&nbsp;23769 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4625923 |
| Progyny, Inc. (a) | Progyny, Inc. (a) | &nbsp;&nbsp;37351 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;693981 |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | 418220 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;154942146 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;229709073 |
| TOTAL HEALTH CARE PROVIDERS & SERVICES | &nbsp;&nbsp;&nbsp;&nbsp;520623755 |  |  |
| **HEALTH CARE TECHNOLOGY – 0.6%** | **HEALTH CARE TECHNOLOGY – 0.6%** | **HEALTH CARE TECHNOLOGY – 0.6%** | **HEALTH CARE TECHNOLOGY – 0.6%** |
| **Health Care Technology – 0.6%** | **Health Care Technology – 0.6%** | **Health Care Technology – 0.6%** | **Health Care Technology – 0.6%** |
| Certara, Inc. (a) | Certara, Inc. (a) | &nbsp;&nbsp;55826 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;342213 |
| Doximity, Inc. Class A (a) | Doximity, Inc. Class A (a) | &nbsp;&nbsp;57862 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1414147 |
| GoodRx Holdings, Inc. Class A (a) | GoodRx Holdings, Inc. Class A (a) | &nbsp;&nbsp;41844 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;98752 |
| HealthStream, Inc. | HealthStream, Inc. | &nbsp;&nbsp;11039 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;229170 |
| HeartFlow, Inc. (a) | HeartFlow, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9563 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;284595 |
| Phreesia, Inc. (a) | Phreesia, Inc. (a) | &nbsp;&nbsp;27318 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;251599 |
| Schrodinger, Inc. (a) | Schrodinger, Inc. (a) | &nbsp;&nbsp;29701 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;355224 |
| Teladoc Health, Inc. (a) | Teladoc Health, Inc. (a) | &nbsp;&nbsp;81058 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;491211 |
| Veeva Systems, Inc. Class A (a) | Veeva Systems, Inc. Class A (a) | &nbsp;&nbsp;71993 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11228748 |
| Waystar Holding Corp. (a) | Waystar Holding Corp. (a) | &nbsp;&nbsp;53588 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1145444 |
| TOTAL HEALTH CARE TECHNOLOGY | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15841103 |  |  |
| **LIFE SCIENCES TOOLS & SERVICES – 8.5%** | **LIFE SCIENCES TOOLS & SERVICES – 8.5%** | **LIFE SCIENCES TOOLS & SERVICES – 8.5%** | **LIFE SCIENCES TOOLS & SERVICES – 8.5%** |
| **Life Sciences Tools & Services – 8.5%** | **Life Sciences Tools & Services – 8.5%** | **Life Sciences Tools & Services – 8.5%** | **Life Sciences Tools & Services – 8.5%** |
| 10X Genomics, Inc. Class A (a) | 10X Genomics, Inc. Class A (a) | &nbsp;&nbsp;48932 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1078951 |
| Adaptive Biotechnologies Corp. (a) | Adaptive Biotechnologies Corp. (a) | &nbsp;&nbsp;52346 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;738079 |
| Agilent Technologies, Inc. | Agilent Technologies, Inc. | 130939 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15130001 |
| Avantor, Inc. (a) | Avantor, Inc. (a) | 316237 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2561520 |
| Azenta, Inc. (a) | Azenta, Inc. (a) | &nbsp;&nbsp;18758 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;460884 |
| BioLife Solutions, Inc. (a) | BioLife Solutions, Inc. (a) | &nbsp;&nbsp;18652 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;393184 |
| Bio-Rad Laboratories, Inc. Class A (a) | Bio-Rad Laboratories, Inc. Class A (a) | &nbsp;&nbsp;&nbsp;&nbsp;8563 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2398667 |
| Bio-Techne Corp. | Bio-Techne Corp. | &nbsp;&nbsp;71837 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3974023 |
| Bruker Corp. | Bruker Corp. | &nbsp;&nbsp;48831 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1792586 |
| Charles River Laboratories International, Inc. (a) | Charles River Laboratories International, Inc. (a) | &nbsp;&nbsp;22674 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3785878 |
| Danaher Corp. | Danaher Corp. | 293505 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52522720 |
| Fortrea Holdings, Inc. (a) | Fortrea Holdings, Inc. (a) | &nbsp;&nbsp;44224 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;508576 |
| Ginkgo Bioworks Holdings, Inc. (a) | Ginkgo Bioworks Holdings, Inc. (a) | &nbsp;&nbsp;16982 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;143668 |

---

 ***Quarterly Report*** <sub>4</sub>

------

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **LIFE SCIENCES TOOLS & SERVICES – continued** | **LIFE SCIENCES TOOLS & SERVICES – continued** | **LIFE SCIENCES TOOLS & SERVICES – continued** | **LIFE SCIENCES TOOLS & SERVICES – continued** |
| **Life Sciences Tools & Services – continued** | **Life Sciences Tools & Services – continued** | **Life Sciences Tools & Services – continued** | **Life Sciences Tools & Services – continued** |
| Illumina, Inc. (a) | Illumina, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;70547 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$8941127 |
| IQVIA Holdings, Inc. (a) | IQVIA Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;78688 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12461818 |
| Medpace Holdings, Inc. (a) | Medpace Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;10364 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4338992 |
| Mettler-Toledo International, Inc. (a) | Mettler-Toledo International, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9423 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12029496 |
| OmniAb, Inc. (a) | OmniAb, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3335 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1567 |
| OmniAb, Inc. (a) | OmniAb, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3335 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1201 |
| Personalis, Inc. (a) | Personalis, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;24438 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;134898 |
| Repligen Corp. (a) | Repligen Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;24698 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2922020 |
| Revvity, Inc. | Revvity, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;52333 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4533084 |
| Sotera Health Co. (a) | Sotera Health Co. (a) | &nbsp;&nbsp;&nbsp;&nbsp;99321 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1545435 |
| Standard BioTools, Inc. (a) | Standard BioTools, Inc. (a) | &nbsp;&nbsp;&nbsp;118488 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;110040 |
| Tempus AI, Inc. Class A (a) | Tempus AI, Inc. Class A (a) | &nbsp;&nbsp;&nbsp;&nbsp;42918 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2381091 |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | &nbsp;&nbsp;&nbsp;173462 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;83081359 |
| Waters Corp. (a) | Waters Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;45335 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14018942 |
| West Pharmaceutical Services, Inc. | West Pharmaceutical Services, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;33185 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9875524 |
| TOTAL LIFE SCIENCES TOOLS & SERVICES | &nbsp;&nbsp;&nbsp;&nbsp;241865331 |  |  |
| **PHARMACEUTICALS – 32.9%** | **PHARMACEUTICALS – 32.9%** | **PHARMACEUTICALS – 32.9%** | **PHARMACEUTICALS – 32.9%** |
| **Pharmaceuticals – 32.9%** | **Pharmaceuticals – 32.9%** | **Pharmaceuticals – 32.9%** | **Pharmaceuticals – 32.9%** |
| Alumis, Inc. (a) | Alumis, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;29655 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;732182 |
| Amneal Pharmaceuticals, Inc. (a) | Amneal Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;71718 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;923011 |
| Amphastar Pharmaceuticals, Inc. (a) | Amphastar Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;17560 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;385618 |
| Amylyx Pharmaceuticals, Inc. (a) | Amylyx Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;30218 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;483488 |
| ANI Pharmaceuticals, Inc. (a) | ANI Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8188 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;650537 |
| Arvinas, Inc. (a) | Arvinas, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;25043 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;247926 |
| AtaiBeckley, Inc. (a) | AtaiBeckley, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;75711 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;314958 |
| Axsome Therapeutics, Inc. (a) | Axsome Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;16077 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3339997 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | &nbsp;&nbsp;&nbsp;939894 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56948177 |
| Collegium Pharmaceutical, Inc. (a) | Collegium Pharmaceutical, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;14683 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;495258 |
| Corcept Therapeutics, Inc. (a) | Corcept Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;43968 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2045391 |
| CorMedix, Inc. (a) | CorMedix, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;34004 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;258090 |
| Crinetics Pharmaceuticals, Inc. (a) | Crinetics Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;41183 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1597077 |
| Definium Therapeutics, Inc. (a) | Definium Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;37154 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;812929 |
| Edgewise Therapeutics, Inc. (a) | Edgewise Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;24144 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;747498 |
| Elanco Animal Health, Inc. (a) | Elanco Animal Health, Inc. (a) | &nbsp;&nbsp;&nbsp;229567 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5135414 |
| Eli Lilly & Co. | Eli Lilly & Co. | &nbsp;&nbsp;&nbsp;371006 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;346742208 |
| Enliven Therapeutics, Inc. (a) | Enliven Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;14804 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;610369 |
| EyePoint, Inc. (a) | EyePoint, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;34174 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;451097 |
| Harmony Biosciences Holdings, Inc. (a) | Harmony Biosciences Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;20410 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;638017 |
| Harrow, Inc. (a) | Harrow, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;14677 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;594859 |
| Indivior Pharmaceuticals, Inc. (a) | Indivior Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;48679 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1790414 |
| Innoviva, Inc. (a) | Innoviva, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;32578 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;748968 |
| Jazz Pharmaceuticals PLC (a) | Jazz Pharmaceuticals PLC (a) | &nbsp;&nbsp;&nbsp;&nbsp;25312 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5138842 |
| Johnson & Johnson | Johnson & Johnson | 1112356 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;255675027 |
| LENZ Therapeutics, Inc. (a) | LENZ Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5375 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48267 |
| Ligand Pharmaceuticals, Inc. (a) | Ligand Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9071 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2081341 |
| Liquidia Corp. (a) | Liquidia Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;28405 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1113760 |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| MBX Biosciences, Inc. (a) | MBX Biosciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;10305 | &nbsp;&nbsp;&nbsp;&nbsp;$311417 |
| Merck & Co., Inc. | Merck & Co., Inc. | 1145934 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;125113074 |
| Nektar Therapeutics (a) | Nektar Therapeutics (a) | &nbsp;&nbsp;&nbsp;&nbsp;14184 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1206207 |
| Nuvation Bio, Inc. (a) | Nuvation Bio, Inc. (a) | &nbsp;&nbsp;&nbsp;101610 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;452164 |
| Ocular Therapeutix, Inc. (a) | Ocular Therapeutix, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;72719 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;681377 |
| Organon & Co. | Organon & Co. | &nbsp;&nbsp;&nbsp;120390 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1595167 |
| Pacira BioSciences, Inc. (a) | Pacira BioSciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;19461 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;496061 |
| Perrigo Co. PLC | Perrigo Co. PLC | &nbsp;&nbsp;&nbsp;&nbsp;62744 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;742889 |
| Pfizer, Inc. | Pfizer, Inc. | 2625054 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;70088942 |
| Phathom Pharmaceuticals, Inc. (a) | Phathom Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;21971 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;246075 |
| Phibro Animal Health Corp. Class A | Phibro Animal Health Corp. Class A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9292 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;494149 |
| Prestige Consumer Healthcare, Inc. (a) | Prestige Consumer Healthcare, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;22052 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1241969 |
| Rapport Therapeutics, Inc. (a) | Rapport Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;13646 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;452092 |
| Royalty Pharma PLC Class A | Royalty Pharma PLC Class A | &nbsp;&nbsp;&nbsp;187394 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9386565 |
| Septerna, Inc. (a) | Septerna, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5127 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;121817 |
| Supernus Pharmaceuticals, Inc. (a) | Supernus Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;26541 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1273968 |
| Tarsus Pharmaceuticals, Inc. (a) | Tarsus Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;14864 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;945499 |
| Terns Pharmaceuticals, Inc. (a) | Terns Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;26088 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1380838 |
| Theravance Biopharma, Inc. (a) | Theravance Biopharma, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;17422 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;291644 |
| Tilray Brands, Inc. (a) | Tilray Brands, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;55676 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;347418 |
| Trevi Therapeutics, Inc. (a) | Trevi Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;44231 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;608619 |
| Viatris, Inc. | Viatris, Inc. | &nbsp;&nbsp;&nbsp;530957 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7932498 |
| WaVe Life Sciences Ltd. (a) | WaVe Life Sciences Ltd. (a) | &nbsp;&nbsp;&nbsp;&nbsp;51175 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;361295 |
| Xeris Biopharma Holdings, Inc. (a) | Xeris Biopharma Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;78052 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;478068 |
| Zoetis, Inc. | Zoetis, Inc. | &nbsp;&nbsp;&nbsp;203465 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23392371 |
| TOTAL PHARMACEUTICALS | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;940392903 |  |  |
| **TOTAL COMMON STOCKS<br> (Cost $2,327,935,690)** | **TOTAL COMMON STOCKS<br> (Cost $2,327,935,690)** | **TOTAL COMMON STOCKS<br> (Cost $2,327,935,690)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2848726813** |
| &nbsp;&nbsp;**Money Market Fund – 0.2%** | &nbsp;&nbsp;**Money Market Fund – 0.2%** | &nbsp;&nbsp;**Money Market Fund – 0.2%** | &nbsp;&nbsp;**Money Market Fund – 0.2%** |
| State Street Institutional Treasury Plus Money Market Fund, Trust Class, 3.54% (b)<br> (Cost $6,674,000) | State Street Institutional Treasury Plus Money Market Fund, Trust Class, 3.54% (b)<br> (Cost $6,674,000) | 6674000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6674000 |
| **TOTAL INVESTMENT IN SECURITIES – 100.0%<br> (Cost $2,334,609,690)** | &nbsp;&nbsp;**2855400813** |  |  |
| **NET OTHER ASSETS (LIABILITIES) (c) – (0.0%)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(959039)** |  |  |
| **NET ASSETS – 100.0%** | **$2854441774** |  |  |

---

---

| | |
|:---|:---|
| **Legend** | **Legend** |
| (a) | Non-income producing. |
| (b) | The rate quoted is the annualized seven-day yield of the fund at period end. |
| (c) | Includes $306,139 of cash collateral to cover margin requirements for futures contracts. |

---

---

| | |
|:---|:---|
| **5** | ***Quarterly Report*** |

---

------

Schedule of Investments (Unaudited)–continued

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** |
|  | **Number of<br> contracts** | &nbsp;&nbsp;**Expiration<br> Date** | &nbsp;&nbsp;**Notional<br> Amount** | &nbsp;&nbsp;**Value** | &nbsp;&nbsp;**Unrealized<br> Appreciation/<br> (Depreciation)** |
| **Purchased** |  |  |  |  |  |
| **Equity Index Contracts** |  |  |  |  |  |
| CME E-mini Health Care Select Sector Index Contracts (United States) | 33 | &nbsp;&nbsp;June 2026 | &nbsp;&nbsp;4883340 | &nbsp;&nbsp;$33255 | &nbsp;&nbsp;$33255 |
| CME E-mini Russell 2000 Index Contracts (United States) | 3 | &nbsp;&nbsp;June 2026 | &nbsp;&nbsp;&nbsp;&nbsp;421170 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5269 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5269 |
| Total Equity Index Contracts |  |  |  |  | &nbsp;&nbsp;&nbsp;$38524 |

---

The notional amount of futures purchased as a percentage of Net Assets is 0.2%

#### Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.

The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:

Level 1 – unadjusted quoted prices in active markets for identical investments

Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 – unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy. If an unaffiliated open-end mutual fund's NAV is unavailable, shares of that fund may be valued by another method that the Board believes reflects fair value in accordance with the Board's fair value pricing policies and is categorized as Level 2 in the hierarchy.

 ***Quarterly Report*** <sub>6</sub>

------

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.

#### Derivative Instruments
Risk Exposures and the Use of Derivative Instruments: The Fund's investment objectives allow the Fund to enter into various types of derivative contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.

The Fund used derivatives to increase returns, to gain exposure to certain types of assets and/or to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the Fund may not achieve its objectives.

The Fund's use of derivatives increased or decreased its exposure to the following risk(s):

Equity Risk - Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment.

Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.

Futures Contracts: A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a specified price at a specified future date.

The Fund used futures contracts to manage its exposure to the stock market.

Open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The underlying face amount at value reflects each contract's exposure to the underlying instrument or index at period end. Any securities and/or cash deposited to meet initial margin requirements are identified in the Schedule of Investments.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

---

| | |
|:---|:---|
| **7** | ***Quarterly Report*** |

---

------

*The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.*

*Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.* 

 ***Quarterly Report*** <sub>8</sub>

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** FIDELITY COVINGTON TRUST

- **b. Investment Company Act file number:** 811-07319

- **c. CIK number of Registrant:** 0000945908

- **d. LEI of Registrant:** 549300JFYFTF85QAQR28

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 245 SUMMER STREET

  - **City:** BOSTON

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02210

  - **Telephone number:** 1-800-FIDELITY

**Item A.2. Information about the Series.**

- **a. Name of Series:** Fidelity MSCI Health Care Index ETF

- **b. EDGAR series identifier (if any):** S000042575

- **c. LEI of Series:** 549300Y1NOU164X4H550

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-07-31

- **b. Date as of which information is reported:** 2026-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $2854899951.60

**Total Liabilities:** $454289.66

**Net Assets:** $2854445661.94

**Cash Not Reported:** $993438.42

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000131667 | 2.94%                | -7.43%               | 0.00%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $4087857.03              | $79067625.89                               |
| Month 2  | $-5180331.78             | $-222688166.66                             |
| Month 3  | $6445369.96              | $-9879776.46                               |

### Schedule of Portfolio Investments

| Name                                         | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Ionis Pharmaceuticals Inc                    | Ionis Pharmaceuticals Inc                                  | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |     70978 | NS      | $5306315.28   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Olema Pharmaceuticals Inc                    | Olema Pharmaceuticals Inc                                  | CUSIP: 68062P106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17308 | NS      | $249408.28    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| MiMedx Group Inc                             | MiMedx Group Inc                                           | CUSIP: 602496101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     52532 | NS      | $176507.52    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Inc                   | Ligand Pharmaceuticals Inc                                 | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |      9071 | NS      | $2081340.95   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| US Physical Therapy Inc                      | US Physical Therapy Inc                                    | CUSIP: 90337L108<br>LEI: 529900KL1UXQYFIOMY96 | Long             | EC               | CORP              | US        |      6857 | NS      | $488355.54    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Charles River Laboratories International Inc | Charles River Laboratories International Inc               | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |     22674 | NS      | $3785877.78   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA HOLOGIC INCORPO                       | CONTRA HOLOGIC INCORPO                                     | CUSIP: 436CVR021<br>LEI: 549300DYP6F5ZJL0LB74 | Long             | EC               | CORP              | US        |    100790 | NS      | $1007.90      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X Genomics Inc                             | 10X Genomics Inc                                           | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |     48932 | NS      | $1078950.60   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA ARCELLX INC                           | CONTRA ARCELLX INC                                         | CUSIP: 039CVR014<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12690 | NS      | $888.30       | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Taysha Gene Therapies Inc                    | Taysha Gene Therapies Inc                                  | CUSIP: 877619106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     62485 | NS      | $399279.15    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Neogen Corp                                  | Neogen Corp                                                | CUSIP: 640491106<br>LEI: 549300HJT9FC36N4UW43 | Long             | EC               | CORP              | US        |     96177 | NS      | $904063.80    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Arrowhead Pharmaceuticals Inc                | Arrowhead Pharmaceuticals Inc                              | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |     56550 | NS      | $4155294.00   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| DENTSPLY SIRONA Inc                          | DENTSPLY SIRONA Inc                                        | CUSIP: 24906P109<br>LEI: 9NHEHR1SOZCYXDO8HO28 | Long             | EC               | CORP              | US        |     91834 | NS      | $1079049.50   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| KalVista Pharmaceuticals Inc                 | KalVista Pharmaceuticals Inc                               | CUSIP: 483497103<br>LEI: 529900Q7IDA3WUGRZA51 | Long             | EC               | CORP              | US        |     13259 | NS      | $353484.94    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc                 | Protagonist Therapeutics Inc                               | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23132 | NS      | $2289374.04   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc                   | Rhythm Pharmaceuticals Inc                                 | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |     26169 | NS      | $2129109.84   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc                  | Alnylam Pharmaceuticals Inc                                | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     60901 | NS      | $18848250.49  | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Waystar Holding Corp                         | Waystar Holding Corp                                       | CUSIP: 946784105<br>LEI: 529900QJLKXDYU36MH89 | Long             | EC               | CORP              | US        |     52484 | NS      | $1121845.50   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Vera Therapeutics Inc                        | Vera Therapeutics Inc                                      | CUSIP: 92337R101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17563 | NS      | $625418.43    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| AMN Healthcare Services Inc                  | AMN Healthcare Services Inc                                | CUSIP: 001744101<br>LEI: 529900W3ARRTCNFH2I39 | Long             | EC               | CORP              | US        |     17137 | NS      | $350794.39    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                                  | Viatris Inc                                                | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    530957 | NS      | $7932497.58   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Relay Therapeutics Inc                       | Relay Therapeutics Inc                                     | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     56820 | NS      | $736387.20    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Newamsterdam Pharma Co NV                    | Newamsterdam Pharma Co NV                                  | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |     21169 | NS      | $604586.64    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Kura Oncology Inc                            | Kura Oncology Inc                                          | CUSIP: 50127T109<br>LEI: 5493005QORQTZCZYOP39 | Long             | EC               | CORP              | US        |     34421 | NS      | $303937.43    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                   | Vertex Pharmaceuticals Inc                                 | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |    116958 | NS      | $49985510.04  | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| SI-BONE Inc                                  | SI-BONE Inc                                                | CUSIP: 825704109<br>LEI: 549300J8JGYVJJHV9C31 | Long             | EC               | CORP              | US        |     18818 | NS      | $233155.02    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                            | Johnson & Johnson                                          | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |   1110650 | NS      | $255282902.50 | 8.94%             |  |  |  | No            |                  1 | On Loan: No      |
| BioCryst Pharmaceuticals Inc                 | BioCryst Pharmaceuticals Inc                               | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |     96151 | NS      | $880743.16    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                       | UnitedHealth Group Inc                                     | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    417583 | NS      | $154706149.84 | 5.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Omnicell Inc                                 | Omnicell Inc                                               | CUSIP: 68213N109<br>LEI: 5493008RH0GTKHHPZI77 | Long             | EC               | CORP              | US        |     21155 | NS      | $876240.10    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Prestige Consumer Healthcare Inc             | Prestige Consumer Healthcare Inc                           | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22052 | NS      | $1241968.64   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| BrightSpring Health Services Inc             | BrightSpring Health Services Inc                           | CUSIP: 10950A106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     66653 | NS      | $3197344.41   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| UroGen Pharma Ltd                            | UroGen Pharma Ltd                                          | CUSIP: 000000000<br>LEI: 549300C0YCX7CG2G5D50 | Long             | EC               | CORP              | IL        |     18033 | NS      | $429726.39    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Repligen Corp                                | Repligen Corp                                              | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |     24698 | NS      | $2922020.38   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| BioLife Solutions Inc                        | BioLife Solutions Inc                                      | CUSIP: 09062W204<br>LEI: 549300G2IVCMC2TJDW72 | Long             | EC               | CORP              | US        |     18652 | NS      | $393184.16    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Revvity Inc                                  | Revvity Inc                                                | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |     52333 | NS      | $4533084.46   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Septerna Inc                                 | Septerna Inc                                               | CUSIP: 81734D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5127 | NS      | $121817.52    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira BioSciences Inc                       | Pacira BioSciences Inc                                     | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19461 | NS      | $496060.89    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| MBX Biosciences Inc                          | MBX Biosciences Inc                                        | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10305 | NS      | $311417.10    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals Inc                 | Catalyst Pharmaceuticals Inc                               | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |     54185 | NS      | $1524224.05   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Brookdale Senior Living Inc                  | Brookdale Senior Living Inc                                | CUSIP: 112463104<br>LEI: LH7MQB13NWY7CJ9VC445 | Long             | EC               | CORP              | US        |    103339 | NS      | $1483948.04   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| UFP Technologies Inc                         | UFP Technologies Inc                                       | CUSIP: 902673102<br>LEI: 549300RJ8LY41HS70C91 | Long             | EC               | CORP              | US        |      3350 | NS      | $641960.50    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                                   | AbbVie Inc                                                 | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    814750 | NS      | $172172970.00 | 6.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc                                | Zymeworks Inc                                              | CUSIP: 98985Y108<br>LEI: 894500AHOYAGYLYZJL67 | Long             | EC               | CORP              | US        |     16794 | NS      | $462506.76    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| AtriCure Inc                                 | AtriCure Inc                                               | CUSIP: 04963C209<br>LEI: 254900B2I6GPHK2EXM59 | Long             | EC               | CORP              | US        |     23082 | NS      | $648835.02    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Health Services Inc                | Universal Health Services Inc                              | CUSIP: 913903100<br>LEI: 549300YGMGQDO0NMJD09 | Long             | EC               | CORP              | US        |     25483 | NS      | $4288024.41   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunome Inc                                 | Immunome Inc                                               | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     42979 | NS      | $985938.26    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Myriad Genetics Inc                          | Myriad Genetics Inc                                        | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |     41272 | NS      | $196042.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc                 | Thermo Fisher Scientific Inc                               | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |    173204 | NS      | $82957787.84  | 2.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Dyne Therapeutics Inc                        | Dyne Therapeutics Inc                                      | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     53716 | NS      | $942715.80    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Axogen Inc                                   | Axogen Inc                                                 | CUSIP: 05463X106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21500 | NS      | $928800.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA CHINOOK THERAPE                       | CONTRA CHINOOK THERAPE                                     | CUSIP: 169CVR016<br>LEI: 549300X0O3003W5QYQ48 | Long             | EC               | CORP              | US        |     24218 | NS      | $0.24         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Theravance Biopharma Inc                     | Theravance Biopharma Inc                                   | CUSIP: 000000000<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |     17422 | NS      | $291644.28    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Phathom Pharmaceuticals Inc                  | Phathom Pharmaceuticals Inc                                | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21971 | NS      | $246075.20    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Teladoc Health Inc                           | Teladoc Health Inc                                         | CUSIP: 87918A105<br>LEI: 549300I2PVFBC9MFAC61 | Long             | EC               | CORP              | US        |     81058 | NS      | $491211.48    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Upstream Bio Inc                             | Upstream Bio Inc                                           | CUSIP: 91678A107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11160 | NS      | $102448.80    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| GRAIL Inc                                    | GRAIL Inc                                                  | CUSIP: 384747101<br>LEI: 2549009XSNESW3VE8024 | Long             | EC               | CORP              | US        |     16096 | NS      | $876910.08    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc                     | Agilent Technologies Inc                                   | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |    130688 | NS      | $15100998.40  | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc                  | BioMarin Pharmaceutical Inc                                | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |     84082 | NS      | $4532860.62   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Geron Corp                                   | Geron Corp                                                 | CUSIP: 374163103<br>LEI: 549300T282D7Z2YESL90 | Long             | EC               | CORP              | US        |    230599 | NS      | $355122.46    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Viridian Therapeutics Inc                    | Viridian Therapeutics Inc                                  | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |     30128 | NS      | $406125.44    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Merit Medical Systems Inc                    | Merit Medical Systems Inc                                  | CUSIP: 589889104<br>LEI: 549300OYTY138SP2CE83 | Long             | EC               | CORP              | US        |     27451 | NS      | $1871609.18   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Alignment Healthcare Inc                     | Alignment Healthcare Inc                                   | CUSIP: 01625V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     77111 | NS      | $1738081.94   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Harrow Inc                                   | Harrow Inc                                                 | CUSIP: 415858109<br>LEI: 529900AP4LIRLNV8A089 | Long             | EC               | CORP              | US        |     14677 | NS      | $594858.81    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Oruka Therapeutics Inc                       | Oruka Therapeutics Inc                                     | CUSIP: 687604108<br>LEI: 529900TG7O4ESUDMGI54 | Long             | EC               | CORP              | US        |      9959 | NS      | $681295.19    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Spyre Therapeutics Inc                       | Spyre Therapeutics Inc                                     | CUSIP: 00773J202<br>LEI: 52990017AIJPRH3HQH40 | Long             | EC               | CORP              | US        |     22417 | NS      | $1668945.65   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| CytomX Therapeutics Inc                      | CytomX Therapeutics Inc                                    | CUSIP: 23284F105<br>LEI: 5493004VW2FW0QLL3345 | Long             | EC               | CORP              | US        |     74256 | NS      | $313360.32    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| IRhythm Holdings Inc                         | IRhythm Holdings Inc                                       | CUSIP: 450056106<br>LEI: 549300FJI72RJGDQS384 | Long             | EC               | CORP              | US        |     14825 | NS      | $1914797.00   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| LifeStance Health Group Inc                  | LifeStance Health Group Inc                                | CUSIP: 53228F101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     80190 | NS      | $607038.30    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Tandem Diabetes Care Inc                     | Tandem Diabetes Care Inc                                   | CUSIP: 875372203<br>LEI: 549300JEPFOD0K4D3I05 | Long             | EC               | CORP              | US        |     31511 | NS      | $615252.28    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The                           | Cooper Cos Inc/The                                         | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |     90338 | NS      | $5682260.20   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| OMNIAB INC                                   | OMNIAB INC                                                 | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3335 | NS      | $1200.60      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc                        | Beam Therapeutics Inc                                      | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     42166 | NS      | $1278894.78   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Therapeutics Inc                     | Compass Therapeutics Inc                                   | CUSIP: 20454B104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51153 | NS      | $90540.81     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Select Medical Holdings Corp                 | Select Medical Holdings Corp                               | CUSIP: 81619Q105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51090 | NS      | $838386.90    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Mineralys Therapeutics Inc                   | Mineralys Therapeutics Inc                                 | CUSIP: 603170101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20978 | NS      | $559063.70    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| DaVita Inc                                   | DaVita Inc                                                 | CUSIP: 23918K108<br>LEI: M2XHYMU3TZNEZURC6H66 | Long             | EC               | CORP              | US        |     17983 | NS      | $2789882.62   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp                | Adaptive Biotechnologies Corp                              | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |     52346 | NS      | $738078.60    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| GoodRx Holdings Inc                          | GoodRx Holdings Inc                                        | CUSIP: 38246G108<br>LEI: 529900ATKYECI45EHV09 | Long             | EC               | CORP              | US        |     41844 | NS      | $98751.84     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc                     | Travere Therapeutics Inc                                   | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     38888 | NS      | $1637962.56   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA AKERO THERAPEUT                       | CONTRA AKERO THERAPEUT                                     | CUSIP: 009CVR044<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |     22341 | NS      | $0.22         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Ginkgo Bioworks Holdings Inc                 | Ginkgo Bioworks Holdings Inc                               | CUSIP: 37611X209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16982 | NS      | $143667.72    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Palvella Therapeutics Inc                    | Palvella Therapeutics Inc                                  | CUSIP: 697947109<br>LEI: 254900AJDH8PAOOI5T33 | Long             | EC               | CORP              | US        |      4496 | NS      | $576926.72    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| HeartFlow Inc                                | HeartFlow Inc                                              | CUSIP: 42238D107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9563 | NS      | $284594.88    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Erasca Inc                                   | Erasca Inc                                                 | CUSIP: 29479A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     78076 | NS      | $831509.40    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Bruker Corp                                  | Bruker Corp                                                | CUSIP: 116794108<br>LEI: LEBZ6VLQ6I8XB1NHVY15 | Long             | EC               | CORP              | US        |     48831 | NS      | $1792586.01   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical Inc                 | Collegium Pharmaceutical Inc                               | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |     14683 | NS      | $495257.59    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals Inc                 | Supernus Pharmaceuticals Inc                               | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |     26541 | NS      | $1273968.00   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                               | AnaptysBio Inc                                             | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |      6418 | NS      | $421855.14    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Novocure Ltd                                 | Novocure Ltd                                               | CUSIP: 000000000<br>LEI: 213800YPP55UMHWA4826 | Long             | EC               | CORP              | JE        |     48035 | NS      | $730612.35    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| CorMedix Inc                                 | CorMedix Inc                                               | CUSIP: 21900C308<br>LEI: 5299006YIA3L0MBW8358 | Long             | EC               | CORP              | US        |     34004 | NS      | $258090.36    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                                | Medtronic PLC                                              | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    590998 | NS      | $47853108.06  | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Agios Pharmaceuticals Inc                    | Agios Pharmaceuticals Inc                                  | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |     25231 | NS      | $706468.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Indivior Pharmaceuticals Inc                 | Indivior Pharmaceuticals Inc                               | CUSIP: 45579U109<br>LEI: 254900MKFFZZSS7N1I14 | Long             | EC               | CORP              | US        |     48679 | NS      | $1790413.62   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Centene Corp                                 | Centene Corp                                               | CUSIP: 15135B101<br>LEI: 549300Z7JJ4TQSQGT333 | Long             | EC               | CORP              | US        |    226652 | NS      | $12168945.88  | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Monte Rosa Therapeutics Inc                  | Monte Rosa Therapeutics Inc                                | CUSIP: 61225M102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14154 | NS      | $271049.10    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Precigen Inc                                 | Precigen Inc                                               | CUSIP: 74017N105<br>LEI: 549300XCWNQU35K64G19 | Long             | EC               | CORP              | US        |     81104 | NS      | $337392.64    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc                    | Intellia Therapeutics Inc                                  | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     50707 | NS      | $683530.36    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Zoetis Inc                                   | Zoetis Inc                                                 | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    203147 | NS      | $23355810.59  | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc                    | Halozyme Therapeutics Inc                                  | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |     54463 | NS      | $3467114.58   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp                       | Boston Scientific Corp                                     | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    683394 | NS      | $39370328.34  | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                   | Zimmer Biomet Holdings Inc                                 | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |     91433 | NS      | $7536822.19   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| CONMED Corp                                  | CONMED Corp                                                | CUSIP: 207410101<br>LEI: Z6C0YCECH9DCU5ZIQW84 | Long             | EC               | CORP              | US        |     14369 | NS      | $526767.54    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| ResMed Inc                                   | ResMed Inc                                                 | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |     67289 | NS      | $14387061.09  | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc                          | Elevance Health Inc                                        | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |    102444 | NS      | $38561970.48  | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Pediatrix Medical Group Inc                  | Pediatrix Medical Group Inc                                | CUSIP: 58502B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39438 | NS      | $887749.38    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc                  | Apellis Pharmaceuticals Inc                                | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |     35150 | NS      | $1439392.50   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                   | Biogen Inc                                                 | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     67622 | NS      | $12799492.16  | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc                 | Madrigal Pharmaceuticals Inc                               | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |      6819 | NS      | $3528082.41   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Inspire Medical Systems Inc                  | Inspire Medical Systems Inc                                | CUSIP: 457730109<br>LEI: 549300XQQCQ7HCJKTW25 | Long             | EC               | CORP              | US        |     12863 | NS      | $722128.82    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| EyePoint Inc                                 | EyePoint Inc                                               | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |     34174 | NS      | $451096.80    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| AdaptHealth Corp                             | AdaptHealth Corp                                           | CUSIP: 00653Q102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     43305 | NS      | $567728.55    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbutus Biopharma Corp                       | Arbutus Biopharma Corp                                     | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | CA        |     64437 | NS      | $270635.40    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp                     | United Therapeutics Corp                                   | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     18852 | NS      | $10771090.20  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| ACADIA Pharmaceuticals Inc                   | ACADIA Pharmaceuticals Inc                                 | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |     54956 | NS      | $1233762.20   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Nutex Health Inc                             | Nutex Health Inc                                           | CUSIP: 67079U306<br>LEI: 254900RSD2OET3HENJ50 | Long             | EC               | CORP              | US        |      1700 | NS      | $202640.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Cullinan Therapeutics Inc                    | Cullinan Therapeutics Inc                                  | CUSIP: 230031106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14784 | NS      | $192931.20    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Addus HomeCare Corp                          | Addus HomeCare Corp                                        | CUSIP: 006739106<br>LEI: 52990090ZT33AKPDBX62 | Long             | EC               | CORP              | US        |      8452 | NS      | $818914.28    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Insulet Corp                                 | Insulet Corp                                               | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |     32471 | NS      | $5589557.94   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Align Technology Inc                         | Align Technology Inc                                       | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |     31438 | NS      | $5533402.38   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc                      | Viking Therapeutics Inc                                    | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |     49795 | NS      | $1552608.10   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Becton Dickinson & Co                        | Becton Dickinson & Co                                      | CUSIP: 075887109<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | EC               | CORP              | US        |    131388 | NS      | $19582067.52  | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Chicago Mercantile Exchange                  | E-MINI RUSS 2000 JUN26                                     | CUSIP: 000000000<br>LEI: SNZ2OJLFK8MNNCLQOF39 | N/A              | DE               |  | US        |         7 | NC      | $27539.15     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Penumbra Inc                                 | Penumbra Inc                                               | CUSIP: 70975L107<br>LEI: 549300RGE06P3ECANU72 | Long             | EC               | CORP              | US        |     17152 | NS      | $5599784.96   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| ANI Pharmaceuticals Inc                      | ANI Pharmaceuticals Inc                                    | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |      8188 | NS      | $650536.60    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc                     | Revolution Medicines Inc                                   | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |     74541 | NS      | $10742848.92  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc                           | IQVIA Holdings Inc                                         | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |     78509 | NS      | $12433470.33  | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems Inc                            | Veeva Systems Inc                                          | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |     71993 | NS      | $11228748.21  | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                  | Moderna Inc                                                | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |    162167 | NS      | $7449951.98   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                                 | Biohaven Ltd                                               | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | VG        |     59940 | NS      | $574824.60    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                                 | Stryker Corp                                               | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |    158669 | NS      | $50001361.97  | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Iovance Biotherapeutics Inc                  | Iovance Biotherapeutics Inc                                | CUSIP: 462260100<br>LEI: 2549002L8WT2ACU5Q878 | Long             | EC               | CORP              | US        |    140923 | NS      | $473501.28    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| ORIC Pharmaceuticals Inc                     | ORIC Pharmaceuticals Inc                                   | CUSIP: 68622P109<br>LEI: 54930033FJRNEYBW0L25 | Long             | EC               | CORP              | US        |     20039 | NS      | $197985.32    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Amphastar Pharmaceuticals Inc                | Amphastar Pharmaceuticals Inc                              | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |     17560 | NS      | $385617.60    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Alumis Inc                                   | Alumis Inc                                                 | CUSIP: 022307102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     29655 | NS      | $732181.95    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphatec Holdings Inc                        | Alphatec Holdings Inc                                      | CUSIP: 02081G201<br>LEI: 549300EZE8CQ8K65FS24 | Long             | EC               | CORP              | US        |     54133 | NS      | $528338.08    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Dianthus Therapeutics Inc                    | Dianthus Therapeutics Inc                                  | CUSIP: 252828108<br>LEI: 549300Z3N6ODPCOFC890 | Long             | EC               | CORP              | US        |     16047 | NS      | $1408926.60   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| STAAR Surgical Co                            | STAAR Surgical Co                                          | CUSIP: 852312305<br>LEI: 5299006LRHI7OJ8BY308 | Long             | EC               | CORP              | US        |     14691 | NS      | $387254.76    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Avanos Medical Inc                           | Avanos Medical Inc                                         | CUSIP: 05350V106<br>LEI: 549300YCXWOM7NEWMQ58 | Long             | EC               | CORP              | US        |     20939 | NS      | $515518.18    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc                | Recursion Pharmaceuticals Inc                              | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    203251 | NS      | $703248.46    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Celldex Therapeutics Inc                     | Celldex Therapeutics Inc                                   | CUSIP: 15117B202<br>LEI: 529900F018DMYWH38923 | Long             | EC               | CORP              | US        |     30973 | NS      | $1018392.24   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Amneal Pharmaceuticals Inc                   | Amneal Pharmaceuticals Inc                                 | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |     71718 | NS      | $923010.66    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Cigna Group/The                              | Cigna Group/The                                            | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |    123144 | NS      | $35783183.52  | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Establishment Labs Holdings Inc              | Establishment Labs Holdings Inc                            | CUSIP: 000000000<br>LEI: 549300BCBQ714JNJ7V58 | Long             | EC               | CORP              | VG        |      7971 | NS      | $547049.73    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicara Therapeutics Inc                      | Bicara Therapeutics Inc                                    | CUSIP: 055477103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12760 | NS      | $275360.80    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Integra LifeSciences Holdings Corp           | Integra LifeSciences Holdings Corp                         | CUSIP: 457985208<br>LEI: WB7IJCYY8YFTENS4O147 | Long             | EC               | CORP              | US        |     29902 | NS      | $315167.08    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Trevi Therapeutics Inc                       | Trevi Therapeutics Inc                                     | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     40477 | NS      | $556963.52    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corp                        | Twist Bioscience Corp                                      | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |     27593 | NS      | $1612810.85   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                       | CRISPR Therapeutics AG                                     | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |     39353 | NS      | $2059736.02   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Disc Medicine Inc                            | Disc Medicine Inc                                          | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11162 | NS      | $736133.90    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                              | CVS Health Corp                                            | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    585200 | NS      | $48741308.00  | 1.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Denali Therapeutics Inc                      | Denali Therapeutics Inc                                    | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |     64790 | NS      | $1212868.80   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                 | Illumina Inc                                               | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |     70313 | NS      | $8911469.62   | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Doximity Inc                                 | Doximity Inc                                               | CUSIP: 26622P107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     57862 | NS      | $1414147.28   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| LivaNova PLC                                 | LivaNova PLC                                               | CUSIP: 000000000<br>LEI: 2138001K2FX6SHK2B339 | Long             | EC               | CORP              | GB        |     25135 | NS      | $1510613.50   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Sana Biotechnology Inc                       | Sana Biotechnology Inc                                     | CUSIP: 799566104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     78026 | NS      | $256705.54    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Hinge Health Inc                             | Hinge Health Inc                                           | CUSIP: 433313103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8122 | NS      | $362241.20    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| MoonLake Immunotherapeutics                  | MoonLake Immunotherapeutics                                | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |     14568 | NS      | $238623.84    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| TransMedics Group Inc                        | TransMedics Group Inc                                      | CUSIP: 89377M109<br>LEI: 549300060GVOSMWARH50 | Long             | EC               | CORP              | US        |     14862 | NS      | $1497940.98   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc                   | Tarsus Pharmaceuticals Inc                                 | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14864 | NS      | $945499.04    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                          | Guardant Health Inc                                        | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     51837 | NS      | $4513965.96   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Tempus AI Inc                                | Tempus AI Inc                                              | CUSIP: 88023B103<br>LEI: 2549009LA0KWRAGQBX50 | Long             | EC               | CORP              | US        |     42918 | NS      | $2381090.64   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc                      | Axsome Therapeutics Inc                                    | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     16077 | NS      | $3339996.75   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Terns Pharmaceuticals Inc                    | Terns Pharmaceuticals Inc                                  | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |     26088 | NS      | $1380837.84   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd                       | WaVe Life Sciences Ltd                                     | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |     51175 | NS      | $361295.50    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ImmunityBio Inc                              | ImmunityBio Inc                                            | CUSIP: 45256X103<br>LEI: 529900J9XLBR4HFL4B83 | Long             | EC               | CORP              | US        |    158131 | NS      | $1122730.10   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Co PLC                               | Perrigo Co PLC                                             | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |     62744 | NS      | $742888.96    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                  | Incyte Corp                                                | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     76855 | NS      | $7321975.85   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                             | Nuvation Bio Inc                                           | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    101610 | NS      | $452164.50    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| GeneDx Holdings Corp                         | GeneDx Holdings Corp                                       | CUSIP: 81663L200<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9194 | NS      | $578210.66    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech Inc                          | Krystal Biotech Inc                                        | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |      9976 | NS      | $2616305.76   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA AKOUOS INC                            | CONTRA AKOUOS INC                                          | CUSIP: 009CVR036<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11863 | NS      | $2253.97      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Globus Medical Inc                           | Globus Medical Inc                                         | CUSIP: 379577208<br>LEI: 5299003M2P4CIK0RF205 | Long             | EC               | CORP              | US        |     51771 | NS      | $4668708.78   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Pennant Group Inc/The                        | Pennant Group Inc/The                                      | CUSIP: 70805E109<br>LEI: 5493007H2OYR6BYLDA64 | Long             | EC               | CORP              | US        |     16336 | NS      | $511643.52    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Amylyx Pharmaceuticals Inc                   | Amylyx Pharmaceuticals Inc                                 | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30218 | NS      | $483488.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| ADMA Biologics Inc                           | ADMA Biologics Inc                                         | CUSIP: 000899104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    109138 | NS      | $1118664.50   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc                       | Intuitive Surgical Inc                                     | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |    163426 | NS      | $74785371.86  | 2.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Hims & Hers Health Inc                       | Hims & Hers Health Inc                                     | CUSIP: 433000106<br>LEI: 254900V041EIVTSB6D58 | Long             | EC               | CORP              | US        |     91178 | NS      | $2477306.26   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Zenas Biopharma Inc                          | Zenas Biopharma Inc                                        | CUSIP: 98937L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7339 | NS      | $141789.48    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| ArriVent Biopharma Inc                       | ArriVent Biopharma Inc                                     | CUSIP: 04272N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9868 | NS      | $306796.12    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                    | Amgen Inc                                                  | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |    248232 | NS      | $85950330.00  | 3.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences Inc                       | Ideaya Biosciences Inc                                     | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |     36855 | NS      | $1072480.50   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Butterfly Network Inc                        | Butterfly Network Inc                                      | CUSIP: 124155102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     93022 | NS      | $445575.38    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| National HealthCare Corp                     | National HealthCare Corp                                   | CUSIP: 635906100<br>LEI: 254900PTS11LS1JS2752 | Long             | EC               | CORP              | US        |      6169 | NS      | $1069026.01   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Medpace Holdings Inc                         | Medpace Holdings Inc                                       | CUSIP: 58506Q109<br>LEI: 549300H8TYEUVTW14A54 | Long             | EC               | CORP              | US        |     10364 | NS      | $4338992.24   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Labcorp Holdings Inc                         | Labcorp Holdings Inc                                       | CUSIP: 504922105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     38214 | NS      | $9813355.20   | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp                                | Liquidia Corp                                              | CUSIP: 53635D202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     28405 | NS      | $1113760.05   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Phreesia Inc                                 | Phreesia Inc                                               | CUSIP: 71944F106<br>LEI: 5493000HHF8NU4QOCG53 | Long             | EC               | CORP              | US        |     27318 | NS      | $251598.78    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Surgery Partners Inc                         | Surgery Partners Inc                                       | CUSIP: 86881A100<br>LEI: 549300LC82HG33S19I03 | Long             | EC               | CORP              | US        |     35045 | NS      | $491681.35    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| CorVel Corp                                  | CorVel Corp                                                | CUSIP: 221006109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14092 | NS      | $809726.32    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardian Pharmacy Services Inc               | Guardian Pharmacy Services Inc                             | CUSIP: 40145W101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11248 | NS      | $417300.80    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Veracyte Inc                                 | Veracyte Inc                                               | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |     36188 | NS      | $1191308.96   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Ensign Group Inc/The                         | Ensign Group Inc/The                                       | CUSIP: 29358P101<br>LEI: 5493003K4HEEA8Q0BC72 | Long             | EC               | CORP              | US        |     26762 | NS      | $4996197.78   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                                 | Organon & Co                                               | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    118299 | NS      | $1567461.75   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                          | Abbott Laboratories                                        | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    801594 | NS      | $72776719.26  | 2.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Privia Health Group Inc                      | Privia Health Group Inc                                    | CUSIP: 74276R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45158 | NS      | $1122176.30   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte Inc                                  | Vaxcyte Inc                                                | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |     54160 | NS      | $3100118.40   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva Inc                                 | Innoviva Inc                                               | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |     32578 | NS      | $748968.22    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Tango Therapeutics Inc                       | Tango Therapeutics Inc                                     | CUSIP: 87583X109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20381 | NS      | $440637.22    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| GE HealthCare Technologies Inc               | GE HealthCare Technologies Inc                             | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |    209991 | NS      | $12775852.44  | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| iRadimed Corp                                | iRadimed Corp                                              | CUSIP: 46266A109<br>LEI: 549300YVHWP0YJ1YW816 | Long             | EC               | CORP              | US        |      3851 | NS      | $321327.44    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Definium Therapeutics Inc                    | Definium Therapeutics Inc                                  | CUSIP: 24477V105<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | CA        |     37154 | NS      | $812929.52    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| CareDx Inc                                   | CareDx Inc                                                 | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               | CORP              | US        |     24115 | NS      | $501833.15    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc                         | Bridgebio Pharma Inc                                       | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |     66688 | NS      | $4742183.68   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Kodiak Sciences Inc                          | Kodiak Sciences Inc                                        | CUSIP: 50015M109<br>LEI: 254900IXI5NI8C9OQE24 | Long             | EC               | CORP              | US        |     13317 | NS      | $579023.16    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                                 | Nuvalent Inc                                               | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18465 | NS      | $1851670.20   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Envista Holdings Corp                        | Envista Holdings Corp                                      | CUSIP: 29415F104<br>LEI: 549300BX623VURJZ5269 | Long             | EC               | CORP              | US        |     76092 | NS      | $1973826.48   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc                    | Xenon Pharmaceuticals Inc                                  | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |     36576 | NS      | $2049719.04   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Aveanna Healthcare Holdings Inc              | Aveanna Healthcare Holdings Inc                            | CUSIP: 05356F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23951 | NS      | $156639.54    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Kymera Therapeutics Inc                      | Kymera Therapeutics Inc                                    | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21910 | NS      | $1776243.70   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Stoke Therapeutics Inc                       | Stoke Therapeutics Inc                                     | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |     18412 | NS      | $602440.64    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Tilray Brands Inc                            | Tilray Brands Inc                                          | CUSIP: 88688T209<br>LEI: 549300Y4V60733TO1478 | Long             | EC               | CORP              | US        |     55676 | NS      | $347418.24    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Dexcom Inc                                   | Dexcom Inc                                                 | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |    179798 | NS      | $10706970.90  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Rapport Therapeutics Inc                     | Rapport Therapeutics Inc                                   | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13646 | NS      | $452091.98    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                                   | Pfizer Inc                                                 | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   2621047 | NS      | $69981954.90  | 2.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Techne Corp                              | Bio-Techne Corp                                            | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |     71837 | NS      | $3974022.84   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Ardelyx Inc                                  | Ardelyx Inc                                                | CUSIP: 039697107<br>LEI: 549300F542QR4SXHCY32 | Long             | EC               | CORP              | US        |    111086 | NS      | $703174.38    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC                     | Jazz Pharmaceuticals PLC                                   | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     25172 | NS      | $5110419.44   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| LENZ Therapeutics Inc                        | LENZ Therapeutics Inc                                      | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5375 | NS      | $48267.50     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| TG Therapeutics Inc                          | TG Therapeutics Inc                                        | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |     69640 | NS      | $2352439.20   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc                    | Edgewise Therapeutics Inc                                  | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24144 | NS      | $747498.24    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Chemed Corp                                  | Chemed Corp                                                | CUSIP: 16359R103<br>LEI: 54930020031IDJT2IM79 | Long             | EC               | CORP              | US        |      6497 | NS      | $2761095.06   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Molina Healthcare Inc                        | Molina Healthcare Inc                                      | CUSIP: 60855R100<br>LEI: 549300NQQCEQ46YHZ591 | Long             | EC               | CORP              | US        |     23769 | NS      | $4625922.78   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc                     | Sarepta Therapeutics Inc                                   | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |     45547 | NS      | $951021.36    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp                    | Edwards Lifesciences Corp                                  | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    267514 | NS      | $22337419.00  | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc                      | Apogee Therapeutics Inc                                    | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17612 | NS      | $1459858.68   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Fulgent Genetics Inc                         | Fulgent Genetics Inc                                       | CUSIP: 359664109<br>LEI: 549300CL6P01M68QJ404 | Long             | EC               | CORP              | US        |      8753 | NS      | $132958.07    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Solventum Corp                               | Solventum Corp                                             | CUSIP: 83444M101<br>LEI: 254900I70403OSGY4M28 | Long             | EC               | CORP              | US        |     72184 | NS      | $4862314.24   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Progyny Inc                                  | Progyny Inc                                                | CUSIP: 74340E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     37351 | NS      | $693981.58    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cardinal Health Inc                          | Cardinal Health Inc                                        | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |    109528 | NS      | $21125760.64  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                                  | Cencora Inc                                                | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |     84961 | NS      | $26168837.61  | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Xeris Biopharma Holdings Inc                 | Xeris Biopharma Holdings Inc                               | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     78052 | NS      | $478068.50    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc                     | Enliven Therapeutics Inc                                   | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14804 | NS      | $610368.92    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Option Care Health Inc                       | Option Care Health Inc                                     | CUSIP: 68404L201<br>LEI: 549300DI3Q5ACSYJRI17 | Long             | EC               | CORP              | US        |     72815 | NS      | $1480328.95   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| LeMaitre Vascular Inc                        | LeMaitre Vascular Inc                                      | CUSIP: 525558201<br>LEI: 549300FZUBUB7MHY8R17 | Long             | EC               | CORP              | US        |      9837 | NS      | $1079610.75   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Embecta Corp                                 | Embecta Corp                                               | CUSIP: 29082K105<br>LEI: 549300RPG8GXVDHNXZ62 | Long             | EC               | CORP              | US        |     25512 | NS      | $233434.80    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| NeoGenomics Inc                              | NeoGenomics Inc                                            | CUSIP: 64049M209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     60531 | NS      | $560517.06    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| OMNIAB INC                                   | OMNIAB INC                                                 | CUSIP: 68218J202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3335 | NS      | $1567.45      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Schrodinger Inc/United States                | Schrodinger Inc/United States                              | CUSIP: 80810D103<br>LEI: 984500044BAE4791E559 | Long             | EC               | CORP              | US        |     29701 | NS      | $355223.96    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Kestra Medical Technologies Ltd              | Kestra Medical Technologies Ltd                            | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | BM        |      9448 | NS      | $195762.56    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Prime Medicine Inc                           | Prime Medicine Inc                                         | CUSIP: 74168J101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39527 | NS      | $140123.22    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                | Ultragenyx Pharmaceutical Inc                              | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     39736 | NS      | $981081.84    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Praxis Precision Medicines Inc               | Praxis Precision Medicines Inc                             | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10867 | NS      | $3464725.61   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                                   | Insmed Inc                                                 | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     98313 | NS      | $13403011.29  | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc                        | Arcus Biosciences Inc                                      | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     40376 | NS      | $1029588.00   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Acadia Healthcare Co Inc                     | Acadia Healthcare Co Inc                                   | CUSIP: 00404A109<br>LEI: 5493005CW985Y9D0NC11 | Long             | EC               | CORP              | US        |     40172 | NS      | $1040253.94   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcutis Biotherapeutics Inc                  | Arcutis Biotherapeutics Inc                                | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     50560 | NS      | $1174003.20   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Vir Biotechnology Inc                        | Vir Biotechnology Inc                                      | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     54198 | NS      | $553632.57    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Celcuity Inc                                 | Celcuity Inc                                               | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |      9556 | NS      | $1159620.60   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Vericel Corp                                 | Vericel Corp                                               | CUSIP: 92346J108<br>LEI: 54930076YM3PLTDR4B91 | Long             | EC               | CORP              | US        |     23722 | NS      | $823865.06    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Harmony Biosciences Holdings Inc             | Harmony Biosciences Holdings Inc                           | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19511 | NS      | $609913.86    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| State Street Global Advisors                 | State Street Institutional Treasury Plus Money Market Fund | CUSIP: 857492862<br>LEI: 549300PNASLVKQG64331 | Long             | STIV             | RF                | US        |   6674000 | NS      | $6674000.00   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| RadNet Inc                                   | RadNet Inc                                                 | CUSIP: 750491102<br>LEI: 529900RECG94V2IZJ970 | Long             | EC               | CORP              | US        |     30424 | NS      | $1720477.20   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                                  | Arvinas Inc                                                | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25043 | NS      | $247925.70    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                          | Nektar Therapeutics                                        | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |     11131 | NS      | $946580.24    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Tenet Healthcare Corp                        | Tenet Healthcare Corp                                      | CUSIP: 88033G407<br>LEI: 0W9AIBT6U6ADJ2I8HK17 | Long             | EC               | CORP              | US        |     40458 | NS      | $7165920.96   | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Azenta Inc                                   | Azenta Inc                                                 | CUSIP: 114340102<br>LEI: 35ZN6X1ANPH25YN32Y17 | Long             | EC               | CORP              | US        |     18758 | NS      | $460884.06    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc                       | Cogent Biosciences Inc                                     | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     38351 | NS      | $1372582.29   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| HealthStream Inc                             | HealthStream Inc                                           | CUSIP: 42222N103<br>LEI: 529900OJ88H8635JNH64 | Long             | EC               | CORP              | US        |     11039 | NS      | $229169.64    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Chicago Mercantile Exchange                  | XAV HEALTH CARE JUN26                                      | CUSIP: 000000000<br>LEI: SNZ2OJLFK8MNNCLQOF39 | N/A              | DE               |  | US        |        61 | NC      | $-71134.66    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                                   | Natera Inc                                                 | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |     60581 | NS      | $12489378.96  | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                   | Neurocrine Biosciences Inc                                 | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     45968 | NS      | $6052606.56   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis Inc                                 | Exelixis Inc                                               | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |    117127 | NS      | $5207466.42   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| HealthEquity Inc                             | HealthEquity Inc                                           | CUSIP: 42226A107<br>LEI: 529900LRJU1RAFQHM467 | Long             | EC               | CORP              | US        |     39344 | NS      | $3227388.32   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| HCA Healthcare Inc                           | HCA Healthcare Inc                                         | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |     73639 | NS      | $31992463.55  | 1.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Standard BioTools Inc                        | Standard BioTools Inc                                      | CUSIP: 34385P108<br>LEI: 549300GX8Y96GSB6YP89 | Long             | EC               | CORP              | US        |    118488 | NS      | $110039.81    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals Inc                | Crinetics Pharmaceuticals Inc                              | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |     41183 | NS      | $1597076.74   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Masimo Corp                                  | Masimo Corp                                                | CUSIP: 574795100<br>LEI: 549300Q4A8JK0PIYCU29 | Long             | EC               | CORP              | US        |     21108 | NS      | $3766300.44   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Rad Laboratories Inc                     | Bio-Rad Laboratories Inc                                   | CUSIP: 090572207<br>LEI: 549300ZC1GPV35XYDK53 | Long             | EC               | CORP              | US        |      8563 | NS      | $2398667.56   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Avantor Inc                                  | Avantor Inc                                                | CUSIP: 05352A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    316237 | NS      | $2561519.70   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| McKesson Corp                                | McKesson Corp                                              | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |     56896 | NS      | $46381619.20  | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                                   | Humana Inc                                                 | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |     55439 | NS      | $13107997.16  | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Fortrea Holdings Inc                         | Fortrea Holdings Inc                                       | CUSIP: 34965K107<br>LEI: 5493000FIVFABOVCDU97 | Long             | EC               | CORP              | US        |     41583 | NS      | $478204.50    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Certara Inc                                  | Certara Inc                                                | CUSIP: 15687V109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     55826 | NS      | $342213.38    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology Inc                              | CG oncology Inc                                            | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19705 | NS      | $1315111.70   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Lantheus Holdings Inc                        | Lantheus Holdings Inc                                      | CUSIP: 516544103<br>LEI: 5299005HUB5IOJGO7S39 | Long             | EC               | CORP              | US        |     30428 | NS      | $2574817.36   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Pulse Biosciences Inc                        | Pulse Biosciences Inc                                      | CUSIP: 74587B101<br>LEI: 529900NJUBI06118FM73 | Long             | EC               | CORP              | US        |      9245 | NS      | $195716.65    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Astrana Health Inc                           | Astrana Health Inc                                         | CUSIP: 03763A207<br>LEI: 5493008O4R82Q4STJ936 | Long             | EC               | CORP              | US        |     20883 | NS      | $712945.62    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics Inc                             | Cytokinetics Inc                                           | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |     53720 | NS      | $3436468.40   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                                 | Danaher Corp                                               | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    293052 | NS      | $52441655.40  | 1.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Haemonetics Corp                             | Haemonetics Corp                                           | CUSIP: 405024100<br>LEI: 549300ZEL6TXZS6F5F95 | Long             | EC               | CORP              | US        |     21461 | NS      | $1289591.49   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Concentra Group Holdings Parent Inc          | Concentra Group Holdings Parent Inc                        | CUSIP: 20603L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     53425 | NS      | $1200459.75   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Inhibrx Biosciences Inc                      | Inhibrx Biosciences Inc                                    | CUSIP: 45720N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3333 | NS      | $430656.93    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                | Regeneron Pharmaceuticals Inc                              | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     47616 | NS      | $33667368.96  | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Ocular Therapeutix Inc                       | Ocular Therapeutix Inc                                     | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |     72719 | NS      | $681377.03    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| ICU Medical Inc                              | ICU Medical Inc                                            | CUSIP: 44930G107<br>LEI: 5493003NRW7LS2QZRH60 | Long             | EC               | CORP              | US        |     10702 | NS      | $1275678.40   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Integer Holdings Corp                        | Integer Holdings Corp                                      | CUSIP: 45826H109<br>LEI: 549300SUD2ED5XG6X569 | Long             | EC               | CORP              | US        |     16022 | NS      | $1418107.22   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Kiniksa Pharmaceuticals International Plc    | Kiniksa Pharmaceuticals International Plc                  | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | GB        |     16563 | NS      | $890758.14    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Teleflex Inc                                 | Teleflex Inc                                               | CUSIP: 879369106<br>LEI: UUL85LWXB4NGSWWXIQ25 | Long             | EC               | CORP              | US        |     20462 | NS      | $2535446.42   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc                       | Nurix Therapeutics Inc                                     | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34589 | NS      | $577636.30    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Enovis Corp                                  | Enovis Corp                                                | CUSIP: 194014502<br>LEI: 635400OP2DYYYMOIYL17 | Long             | EC               | CORP              | US        |     26221 | NS      | $614620.24    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc                   | Syndax Pharmaceuticals Inc                                 | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |     37483 | NS      | $803260.69    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| OPKO Health Inc                              | OPKO Health Inc                                            | CUSIP: 68375N103<br>LEI: 529900A4S2D4OGOJLL02 | Long             | EC               | CORP              | US        |    200102 | NS      | $225114.75    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                               | Immunovant Inc                                             | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     36741 | NS      | $997334.45    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Ardent Health Inc                            | Ardent Health Inc                                          | CUSIP: 03980N107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13112 | NS      | $127973.12    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Glaukos Corp                                 | Glaukos Corp                                               | CUSIP: 377322102<br>LEI: 5299004JA1LHE21M6T14 | Long             | EC               | CORP              | US        |     26450 | NS      | $3800071.50   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Mettler-Toledo International Inc             | Mettler-Toledo International Inc                           | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |      9423 | NS      | $12029496.03  | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Artivion Inc                                 | Artivion Inc                                               | CUSIP: 228903100<br>LEI: 549300YTKV8DMSMG6K81 | Long             | EC               | CORP              | US        |     18392 | NS      | $658985.36    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| QuidelOrtho Corp                             | QuidelOrtho Corp                                           | CUSIP: 219798105<br>LEI: 549300YU8CMO9HF53113 | Long             | EC               | CORP              | US        |     31649 | NS      | $389282.70    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Encompass Health Corp                        | Encompass Health Corp                                      | CUSIP: 29261A100<br>LEI: 549300FVRPM9DRQZRG64 | Long             | EC               | CORP              | US        |     46407 | NS      | $4640700.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Aurinia Pharmaceuticals Inc                  | Aurinia Pharmaceuticals Inc                                | CUSIP: 05156V102<br>LEI: 5299008YP2BW4570ML28 | Long             | EC               | CORP              | CA        |     52025 | NS      | $800404.63    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Soleno Therapeutics Inc                      | Soleno Therapeutics Inc                                    | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |     21263 | NS      | $1123111.66   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Personalis Inc                               | Personalis Inc                                             | CUSIP: 71535D106<br>LEI: 549300EZ2NYFK7H0US48 | Long             | EC               | CORP              | US        |     24438 | NS      | $134897.76    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Savara Inc                                   | Savara Inc                                                 | CUSIP: 805111101<br>LEI: 5493002JO0WM3YMJXG33 | Long             | EC               | CORP              | US        |     31710 | NS      | $166160.40    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Phibro Animal Health Corp                    | Phibro Animal Health Corp                                  | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |      9292 | NS      | $494148.56    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                                 | Alkermes PLC                                               | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     72512 | NS      | $2444379.52   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Elanco Animal Health Inc                     | Elanco Animal Health Inc                                   | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |    229567 | NS      | $5135413.79   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Sotera Health Co                             | Sotera Health Co                                           | CUSIP: 83601L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     97516 | NS      | $1517348.96   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                               | Merck & Co Inc                                             | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |   1144186 | NS      | $124922227.48 | 4.38%             |  |  |  | No            |                  1 | On Loan: No      |
| PACS Group Inc                               | PACS Group Inc                                             | CUSIP: 69380Q107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21995 | NS      | $737932.25    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Procept Biorobotics Corp                     | Procept Biorobotics Corp                                   | CUSIP: 74276L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25362 | NS      | $609702.48    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Quest Diagnostics Inc                        | Quest Diagnostics Inc                                      | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |     51278 | NS      | $9958187.60   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| STERIS PLC                                   | STERIS PLC                                                 | CUSIP: 000000000<br>LEI: 549300BRDKZ1HFI2J358 | Long             | EC               | CORP              | IE        |     45282 | NS      | $9820760.16   | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Clover Health Investments Corp               | Clover Health Investments Corp                             | CUSIP: 18914F103<br>LEI: 5493000HLYOYQU6LK133 | Long             | EC               | CORP              | US        |    191101 | NS      | $525527.75    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp                    | Scholar Rock Holding Corp                                  | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |     28968 | NS      | $1350198.48   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| West Pharmaceutical Services Inc             | West Pharmaceutical Services Inc                           | CUSIP: 955306105<br>LEI: 5493007NKRGM1RJQ1P16 | Long             | EC               | CORP              | US        |     33185 | NS      | $9875524.15   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics Inc                         | PTC Therapeutics Inc                                       | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |     33415 | NS      | $2173979.90   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Capricor Therapeutics Inc                    | Capricor Therapeutics Inc                                  | CUSIP: 14070B309<br>LEI: 5493002ZI5PDLXV4DX14 | Long             | EC               | CORP              | US        |     22465 | NS      | $754374.70    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp                                  | Waters Corp                                                | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |     45335 | NS      | $14018942.05  | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                               | Eli Lilly & Co                                             | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    370443 | NS      | $346216027.80 | 12.13%            |  |  |  | No            |                  1 | On Loan: No      |
| Novavax Inc                                  | Novavax Inc                                                | CUSIP: 670002401<br>LEI: 529900J4GJHPEPQ23205 | Long             | EC               | CORP              | US        |     62651 | NS      | $496509.18    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| First Tracks Biotherapeutics Inc             | First Tracks Biotherapeutics Inc                           | CUSIP: 337185102<br>LEI: 529900CGIGKN4R5RO925 | Long             | EC               | CORP              | US        |      6418 | NS      | $149346.86    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Henry Schein Inc                             | Henry Schein Inc                                           | CUSIP: 806407102<br>LEI: VGO3WGL8H45T73F4RR92 | Long             | EC               | CORP              | US        |     48980 | NS      | $3653418.20   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure NV                                   | uniQure NV                                                 | CUSIP: 000000000<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |     18008 | NS      | $359259.60    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                           | Royalty Pharma PLC                                         | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    186793 | NS      | $9356461.37   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirum Pharmaceuticals Inc                    | Mirum Pharmaceuticals Inc                                  | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |     17493 | NS      | $1702243.83   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd                         | Roivant Sciences Ltd                                       | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | BM        |    173133 | NS      | $4939484.49   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| AtaiBeckley Inc                              | AtaiBeckley Inc                                            | CUSIP: 04650F101<br>LEI: 529900HOVZ0MXOBQ5Y47 | Long             | EC               | CORP              | US        |     75711 | NS      | $314957.76    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Castle Biosciences Inc                       | Castle Biosciences Inc                                     | CUSIP: 14843C105<br>LEI: 2549007M2Q4HLR1XD252 | Long             | EC               | CORP              | US        |     13531 | NS      | $331374.19    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics Inc                     | Corcept Therapeutics Inc                                   | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |     43968 | NS      | $2045391.36   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories Inc                       | IDEXX Laboratories Inc                                     | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |     36805 | NS      | $20640244.00  | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Annexon Inc                                  | Annexon Inc                                                | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     54687 | NS      | $321012.69    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Baxter International Inc                     | Baxter International Inc                                   | CUSIP: 071813109<br>LEI: J5OIVXX3P24RJRW5CK77 | Long             | EC               | CORP              | US        |    237837 | NS      | $4181174.46   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co                      | Bristol-Myers Squibb Co                                    | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    938456 | NS      | $56861049.04  | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| ARS Pharmaceuticals Inc                      | ARS Pharmaceuticals Inc                                    | CUSIP: 82835W108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     24917 | NS      | $205814.42    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor Inc                                   | Xencor Inc                                                 | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |     22923 | NS      | $273471.39    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Tyra Biosciences Inc                         | Tyra Biosciences Inc                                       | CUSIP: 90240B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6122 | NS      | $212739.50    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                          | Gilead Sciences Inc                                        | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    571936 | NS      | $74832106.24  | 2.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Janux Therapeutics Inc                       | Janux Therapeutics Inc                                     | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17660 | NS      | $253774.20    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| MannKind Corp                                | MannKind Corp                                              | CUSIP: 56400P706<br>LEI: 213800GFBCNY1ZFST722 | Long             | EC               | CORP              | US        |    135688 | NS      | $383997.04    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-05-29

**Name of Applicant:** FIDELITY COVINGTON TRUST

**Signature:** Stacie M Smith

**Name of Signer:** Stacie M Smith

**Title:** President and Treasurer